Working...
ClinicalTrials.gov

Key Record Dates

ClinicalTrials.gov Identifier: NCT03322267
Brief Title: Adjuvant Pembrolizumab for Patients With Locally Advanced Esophageal Squamous Cell Carcinoma at High Risk of Recurrence

First Submitted : October 16, 2017
First Submitted that Met QC Criteria : October 24, 2017
First Posted : October 26, 2017

Last Update Submitted that Met QC Criteria : November 4, 2018
Last Update Posted : November 6, 2018